Elixirr International Plc (LSE:ELIX), the London-based consultancy group, reported a sharp rise in first-half Revenue alongside a much higher net Debt position. The central question is how the company is financing growth that has been driven substantially by acquisitions, and what the Balance Sheet and Cash Flow figures in its interim results indicate.

A consultancy built partly through acquisitions

Elixirr is a consultancy that advises clients on strategy, digital transformation, data, artificial intelligence and related areas. Over several years it has added specialist firms to its group, including TRC Advisory and, in January 2026, Kvadrant Consulting, which the company said gives it a Nordic presence and adds commercial transformation and private Capital advisory capabilities. The shares moved from AIM to the London Stock Exchange's Main Market in July 2025.

The interim results

On 21 September 2026, Elixirr published results for the six months to 30 June 2026. The company reported revenue of £89.0m, up 25% on the prior year. Organic growth at constant currency was 5%, which indicates that most of the headline increase came from businesses acquired rather than from the existing group. Adjusted EBITDA rose 29% to £27.6m, lifting the adjusted EBITDA Margin to 31.0% from 30.0%. Statutory profit before tax was £18.0m, up 17%, and adjusted Diluted Earnings per Share increased 18% to 34.2p.

A day later, on 22 September 2026, the company issued a short clarification confirming that Cavendish Capital Markets and Canaccord Genuity are its joint corporate brokers, responding to what it called inaccurate commentary in the market.

Balance sheet and cash flow

The figures that stand out are on the balance sheet. Elixirr reported net debt of £56.5m at the half-year end, compared with £6.8m a year earlier, reflecting Acquisition funding. Free cash flow fell to £1.8m from £7.9m. The company attributed the weaker cash generation to seasonal differences and to longer debtor terms inherited in acquired businesses. It paid £11.3m in dividends during the period.

On the commercial side, the company said 35 clients generated more than £1m of revenue, up from 31, and 24 generated more than £2m, up from 16. Cross-sell revenue rose 27% to £19m. AI-related revenue increased by 185% to £8.1m, according to the results. In his commentary, the chief executive cited industry estimates suggesting that "agentic AI alone could create up to $200 billion of new demand" over five years. The company also said it had significantly expanded its partner team while holding revenue per partner at 2025 levels, with experienced hires including Chris Bannocks, Hugh Aller and Tom Andrews. The board said it expects full-year adjusted EBITDA to be in line with market expectations, with revenue broadly in line.

Risks and developments to watch

The company did not identify new principal risks, but its existing list includes talent recruitment and retention, integration of acquisitions, reputation, utilisation and access to capital. Higher borrowing increases exposure to interest costs and makes cash conversion more important. The difference between headline and organic growth suggests that sustaining expansion may depend on further acquisitions or a pick-up in organic demand. Consultancy spending can also be cut quickly when clients face economic uncertainty. A larger partner team probably raises fixed costs, making utilisation important if client Demand softens. Shareholders are likely to watch whether free cash flow recovers in the second half and whether acquired businesses align their payment terms with the rest of the group.

Conclusion

Elixirr funded its recent acquisition-led growth largely through borrowing, taking net debt to £56.5m while free cash flow weakened in the first half. The reported results show higher revenue, earnings and margins, but the gap between total and organic growth means balance sheet discipline and cash conversion are central to assessing the strategy over the coming periods.